Patent: 9,233,142
Summary for Patent: 9,233,142
| Title: | Therapeutic agent for infections, and treatment method using same |
| Abstract: | (Problems) To provide a therapeutic agent for infections comprising granulysin as an active ingredient which has little side effect and no cytotoxicity and to which bacteria can hardly acquire resistance, and a treatment method using the same.(Means for Solving Problems) The present invention provides a therapeutic agent for infections comprising as active ingredient: 15K granulysin, a combination of 15K granulysin and 15K granulysin in vivo expression vector, a combination of 15K granulysin and at least one interleukin selected from IL-6, IL-23 or IL-27, a combination of 15K granulysin in vivo expression vector and at least one interleukin selected from IL-6, IL-23 or IL-27, or a combination of 15K granulysin in vivo expression vector and HSP65DNA and IL-12DNA in vivo expression vector, which enhances killing effects on bacteria and has less side effect, and to which bacteria can hardly acquire resistance, and a treatment method using the same. |
| Inventor(s): | Masaji Okada, Yasushi Takamori, Kazuyuki Ogawa, Kinya Nagata |
| Assignee: | OKADA MASAJI 27% , Azbio Corp , Kinki Chuo Chest Medical Center |
| Application Number: | US14/292,940 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,233,142
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Btg International Inc. | VORAXAZE | glucarpidase | For Injection | 125327 | January 17, 2012 | ⤷ Start Trial | 2034-06-02 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,233,142
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2003211274 | ⤷ Start Trial |
| Canada | 2485882 | ⤷ Start Trial |
| China | 101869714 | ⤷ Start Trial |
| China | 1635902 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
